IL Cicero의 비소세포폐암 임상 시험
비소세포폐암 관련 연구 24개가 Cicero 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
피험자 모집 중1/2상
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · 10마일 거리
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
피험자 모집 중3상
- Edward Hines Jr VA Hospital, Hines · 4마일 거리
- Advocate Christ Medical Center, Oak Lawn · 9마일 거리
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
피험자 모집 중3상
- Northwestern Medicine Oak Brook, Oak Brook · 9마일 거리
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
피험자 모집 중3상
- Hope and Healing Cancer Services, Hinsdale · 10마일 거리
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
피험자 모집 중3상
- Advocate Christ Medical Center, Oak Lawn · 9마일 거리
- Hope and Healing Cancer Services, Hinsdale · 10마일 거리
- Endeavor Health, Elmhurst · 10마일 거리
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
피험자 모집 중2상
- Hope and Healing Clinical Research, Hinsdale · 10마일 거리
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
피험자 모집 중3상
- Research Site, Hinsdale · 10마일 거리
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
피험자 모집 중3상
- Affiliated Oncologists, LLC, Chicago Ridge · 10마일 거리
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
피험자 모집 중3상
- Research Site, Hinsdale · 10마일 거리
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
피험자 모집 중2/3상
- Loyola University Medical Center, Maywood · 5마일 거리
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
피험자 모집 중3상
- Hope and Healing Cancer Services, Hinsdale · 10마일 거리
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
피험자 모집 중3상
- Affiliated Oncologists, LLC, Chicago Ridge · 10마일 거리
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
피험자 모집 중3상
- Research Site, Hinsdale · 10마일 거리
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
피험자 모집 중3상
- Research Site, Hinsdale · 10마일 거리
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
피험자 모집 중3상
- Northwestern Medicine Oak Brook, Oak Brook · 9마일 거리
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
피험자 모집 중3상
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · 10마일 거리
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
피험자 모집 중2상
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3마일 거리
- Edward Hines Jr VA Hospital, Hines · 4마일 거리
- Loyola University Medical Center, Maywood · 5마일 거리
- 외 2개
MYLUNG Consortium Part 3: Observational Study
피험자 모집 중관찰 연구
- Affiliated Oncologists, LLC, Chicago Ridge · 10마일 거리
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2상
- Edward Hines Jr VA Hospital, Hines · 4마일 거리
- Loyola University Medical Center, Maywood · 5마일 거리
- Northwestern Medicine Oak Brook, Oak Brook · 9마일 거리
- 외 3개
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2/3상
- Loyola University Medical Center, Maywood · 5마일 거리
- Northwestern Medicine Oak Brook, Oak Brook · 9마일 거리
- Advocate Christ Medical Center, Oak Lawn · 9마일 거리
- 외 2개
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2상
- Edward Hines Jr VA Hospital, Hines · 4마일 거리
- Loyola University Medical Center, Maywood · 5마일 거리
- Northwestern Medicine Oak Brook, Oak Brook · 9마일 거리
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
피험자 모집 중관찰 연구
- Advocate Christ Medical Center, Oak Lawn · 9마일 거리
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9마일 거리
- Advocate High Tech Medical Park, Palos Heights · 12마일 거리
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
피험자 모집 중
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4마일 거리
GEMINI-NSCLC: NSCLC Biomarker Study
피험자 모집 중관찰 연구
- Hope and Healing Cancer Services, Hinsdale · 10마일 거리
다른 도시의 비소세포폐암 시험
- Houston, TX연구 145개
- New York City, NY연구 121개
- Arlington, VA연구 104개
- Nashville, TN연구 97개
- Boston, MA연구 90개
- Los Angeles, CA연구 87개
- St. Louis, MO연구 73개
- Chicago, IL연구 61개
- Baltimore, MD연구 60개
- San Antonio, TX연구 59개
- Columbus, OH연구 57개
- Washington, DC연구 55개
Cicero의 다른 연구
- 폐암연구 17개
- 전립선암연구 14개
- 암 (전체)연구 13개
- 유방암연구 11개
- 급성 골수성 백혈병연구 11개
- 대장직장암연구 10개
- 방광암연구 8개
- 흑색종연구 7개
- 심혈관 질환연구 7개
- 전이성 암연구 7개
- 다발성 골수종연구 6개
- 버킷 림프종연구 6개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.